Total Payments
$155,222
2024 Payments
$8,270
Companies
57
Transactions
1,078
Medicare Patients
1,594
Medicare Billing
$199,005
Payment Breakdown by Category
Other$125,665 (81.0%)
Food & Beverage$18,938 (12.2%)
Consulting$6,977 (4.5%)
Travel$3,304 (2.1%)
Education$338.96 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,452 | 88 | 77.0% |
| Food and Beverage | $18,938 | 960 | 12.2% |
| Consulting Fee | $6,977 | 3 | 4.5% |
| Honoraria | $6,213 | 3 | 4.0% |
| Travel and Lodging | $3,304 | 15 | 2.1% |
| Education | $338.96 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $47,073 | 117 | $0 (2024) |
| Allergan, Inc. | $42,680 | 65 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $16,119 | 21 | $0 (2021) |
| Lilly USA, LLC | $12,335 | 54 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $8,038 | 14 | $0 (2022) |
| SK Life Science, Inc. | $7,604 | 73 | $0 (2024) |
| Biogen, Inc. | $6,568 | 42 | $0 (2024) |
| Lundbeck LLC | $2,144 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,810 | 75 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,146 | 62 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,270 | 151 | Lilly USA, LLC ($5,925) |
| 2023 | $3,042 | 156 | AbbVie Inc. ($545.39) |
| 2022 | $26,760 | 179 | Biohaven Pharmaceutical Holding Company Ltd. ($8,038) |
| 2021 | $66,891 | 176 | AbbVie Inc. ($42,653) |
| 2020 | $44,490 | 150 | Allergan, Inc. ($39,945) |
| 2019 | $1,782 | 98 | Teva Pharmaceuticals USA, Inc. ($255.64) |
| 2018 | $2,160 | 91 | ACADIA Pharmaceuticals Inc ($449.15) |
| 2017 | $1,827 | 77 | ACADIA Pharmaceuticals Inc ($463.12) |
All Payment Transactions
1,078 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: Central Nervous System | ||||||
| 12/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: EPILEPSY | ||||||
| 12/05/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Neurology | ||||||
| 11/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Neurology | ||||||
| 11/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Neurology | ||||||
| 11/14/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Neurology | ||||||
| 11/07/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Neurology | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/01/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: EPILEPSY | ||||||
| 10/31/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 351 | 586 | $131,483 | $50,623 |
| 2022 | 6 | 346 | 516 | $126,531 | $45,145 |
| 2021 | 5 | 417 | 691 | $164,516 | $60,736 |
| 2020 | 9 | 480 | 639 | $134,952 | $42,501 |
Total Patients
1,594
Total Services
2,432
Medicare Billing
$199,005
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 479 | $100,354 | $39,556 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $24,036 | $8,576 | 35.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 18 | $5,238 | $1,628 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $1,855 | $862.16 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 326 | $74,002 | $28,027 | 37.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 67 | 72 | $21,672 | $7,186 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $17,748 | $5,615 | 31.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 35 | $5,705 | $1,869 | 32.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 20 | 20 | $4,440 | $1,272 | 28.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,964 | $1,177 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 235 | 501 | $113,727 | $44,453 | 39.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $30,276 | $9,561 | 31.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 46 | 47 | $10,434 | $3,561 | 34.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 29 | 29 | $8,729 | $2,874 | 32.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 27 | $1,350 | $286.47 | 21.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 108 | 108 | $37,584 | $11,595 | 30.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 123 | 150 | $34,050 | $10,321 | 30.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 138 | 205 | $30,955 | $9,967 | 32.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 35 | 36 | $10,836 | $3,758 | 34.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 48 | $7,824 | $2,298 | 29.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $5,328 | $1,712 | 32.1% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2020 | 19 | 35 | $3,850 | $1,589 | 41.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $2,925 | $971.64 | 33.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 15 | 32 | $1,600 | $288.93 | 18.1% |
About Dr. Raymond Capps, MD
Dr. Raymond Capps, MD is a Neurology healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346444742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raymond Capps, MD has received a total of $155,222 in payments from pharmaceutical and medical device companies, with $8,270 received in 2024. These payments were reported across 1,078 transactions from 57 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($119,452).
As a Medicare-enrolled provider, Capps has provided services to 1,594 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $199,005. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Murfreesboro, TN
- Active Since 06/12/2007
- Last Updated 09/15/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1346444742
Products in Payments
- UBRELVY (Drug) $87,194
- NURTEC ODT (Drug) $24,299
- XCOPRI (Drug) $6,457
- KISUNLA (Drug) $5,867
- QULIPTA (Drug) $2,118
- VYEPTI (Biological) $2,003
- NUPLAZID (Drug) $1,146
- Aimovig (Biological) $653.64
- NUEDEXTA (Drug) $555.15
- AJOVY (Drug) $530.64
- AUBAGIO (Drug) $377.78
- AUSTEDO (Drug) $367.94
- VALTOCO (Drug) $346.57
- APTIOM (Drug) $333.11
- TROKENDI XR (Drug) $331.33
- INGREZZA (Drug) $318.12
- TYSABRI (Biological) $311.30
- Briviact (Drug) $304.28
- ULTOMIRIS (Biological) $298.47
- Fycompa (Drug) $287.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Murfreesboro
Dr. Ram Narayan Kaveer Nandigam, M.d, M.D
Neurology — Payments: $17,380
Neurology $17,380
Dr. Jesse Kellum, M.d, M.D
Neurology — Payments: $11,280
Neurology $11,280
Mrs. Stacy Gilbert, Agnp, AGNP
Neurology — Payments: $1,204
Neurology $1,204
Dr. Deka Efobi, Md, MD
Neurology — Payments: $769.26
Neurology $769.26
Dr. Sabrina Ahmed, M.d, M.D
Neurology — Payments: $323.09
Neurology $323.09
Nicole Wysocki, M.d, M.D
Neurology — Payments: $148.41
Neurology $148.41